Log in or Sign up for Free to view tailored content for your specialty!
Chronic Kidney Disease News
SGLT2 inhibitors greatly underprescribed in patients who qualify for them
In an analysis of more than 3 million U.S. adults, most patients with a class 1a recommendation for SGLT2 inhibitors were not prescribed them, researchers reported in the Journal of the American College of Cardiology.
Value-based solutions can improve depression management for patients with CKD
Depression is one of the most common complications of chronic illness. Depressive symptoms can have a negative effect on a person’s overall health and quality of life, while the hardships of a chronic illness can take a toll on mental health, creating a vicious cycle of deteriorating behavioral and physical health.
Log in or Sign up for Free to view tailored content for your specialty!
Pharmacist-led optimal medication management is achievable in a value-based care model
In March 2020, a group of nephrology pharmacists met to discuss ways to help improve patient lives and keep the nephrologist at the center of the patient care team.
Early identification, treatment of depression in patients with CKD has long-term benefits
Managing patients with an illness like chronic kidney disease can be difficult at times for caregivers, but Michelle Rowlett, MSW, LICSW, knows that for patients grappling with a disease that can last a lifetime, it poses many challenges.
Phase 3 results for pegcetacoplan show reduced proteinuria, stabilized eGFR vs. placebo
Sobi and Apellis Pharmaceuticals Inc. announced results from the phase 3 Valiant study showing the drug pegcetacoplan reduced proteinuria and stabilized eGFR compared to placebo in patients with glomerulopathy or glomerulonephritis.
Higher protein intake may be linked to lower mortality in some older adults with CKD
Higher intake of total, animal and plant protein may be linked to lower mortality in older adults with mild or moderate chronic kidney disease, according to a cohort study.
Novartis receives FDA approval for Fabhalta to treat IgA nephropathy
The FDA has granted accelerated approval for Fabhalta to treat proteinuria in patients with primary IgA nephropathy, according to a press release.
Meta Pharmaceuticals receives FDA rare pediatric disease designation for META-001-PH
Meta Pharmaceuticals has received FDA rare pediatric disease designation for its investigational new drug META-001-PH, according to a press release.
Study: Many US dialysis providers may have limited knowledge about dementia care
Many dialysis care providers in the United States may have limited knowledge about dementia, according to a web-based survey.
Nutritional risk may be linked to infection-, not cardiovascular-related, hospitalizations
Higher nutritional risk may be associated with infection-related hospitalization but not cardiovascular disease-related hospitalization in patients on dialysis, according to results of a prospective study.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read